Compare NWE & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NWE | STVN |
|---|---|---|
| Founded | 1923 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Power Generation | Containers/Packaging |
| Sector | Utilities | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 3.7B |
| IPO Year | 2023 | 2021 |
| Metric | NWE | STVN |
|---|---|---|
| Price | $70.36 | $18.43 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $66.50 | $25.67 |
| AVG Volume (30 Days) | ★ 413.1K | 309.9K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.76% | 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $1,610,559,000.00 | N/A |
| Revenue This Year | $8.84 | $9.67 |
| Revenue Next Year | $5.31 | $9.99 |
| P/E Ratio | $67.58 | ★ $27.15 |
| Revenue Growth | ★ 6.38 | N/A |
| 52 Week Low | $50.46 | $12.89 |
| 52 Week High | $75.18 | $28.00 |
| Indicator | NWE | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 48.96 | 60.71 |
| Support Level | $68.93 | $17.23 |
| Resistance Level | $71.81 | $19.05 |
| Average True Range (ATR) | 1.43 | 0.70 |
| MACD | -0.24 | -0.06 |
| Stochastic Oscillator | 52.99 | 48.03 |
NorthWestern Energy Group Inc provides electricity and natural gas services in the Upper Midwest and Northwest of the U.S. in the states of Montana, South Dakota, Nebraska, and Yellowstone National Park. The company's primary segments include Electric, which includes the generation, purchase, transmission, and distribution of electricity, and Natural Gas, which includes the production, purchase, transmission, storage, and distribution of natural gas. It uses thermal, wind, hydro, or renewable energy in varying quantities, depending on the location of the facilities, to generate power. The company derives the majority of its revenue from the Electric segment.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, It derives its majority revenue from Europe, Middle East and Africa.